Literature DB >> 18822646

Deliberate self-poisoning: experience at a medical unit.

Muhammad Khurram1, Najia Mahmood.   

Abstract

To share our experience of managing acute DSP patients, a cross sectional, observational study was conducted for one year. Patients with acute DSP, defined as "ingestion of a poison or excessive dose of a medicine for self-harm" were included. Patient demographics (gender, age, educational, and marital status etc), intention, substance used, and outcome were noted. Eighty patients (47 female, and 33 male) were managed. Mean patient age was 24.35 +/- 7.69 years. Most of the patients were educated up to 10th grade, were unmarried, resident of urban area, occupation wise household related, and belonged to middle class. Majority (55%) of patients wanted to commit suicide. Benzodiazepines (31.3%) and organophosphate (OP) compounds (21.3%) were commonly used for DSP. 2.5% (n = 2) patients expired. DSP with OP compounds was significantly associated with suicidal intention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18822646

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  3 in total

1.  The Current State of Poison Control Centers in Pakistan and the Need for Capacity Building.

Authors:  Nadeem Ullah Khan1; Mohammed Umer Mir; Uzma Rahim Khan; Afshan Rahim Khan; Jamal Ara; Khurram Raja; Farhat Hussain Mirza
Journal:  Asia Pac J Med Toxicol       Date:  2014

Review 2.  Suicide and deliberate self-harm in Pakistan: a scoping review.

Authors:  Sualeha S Shekhani; Shagufta Perveen; Dur-E-Sameen Hashmi; Khawaja Akbar; Sara Bachani; Murad M Khan
Journal:  BMC Psychiatry       Date:  2018-02-12       Impact factor: 3.630

3.  Epidemiological and cost analysis of self-poisoning cases in ankara, Turkey.

Authors:  Gulsum Kavalci; Filiz Banu Ethemoglu; Asli Batuman; Dilber Kumral; Cengizhan Emre; Meltem Surgit; Alev Akdikan; Cemil Kavalci
Journal:  Iran Red Crescent Med J       Date:  2014-11-17       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.